Neurological Manifestations of Long COVID: A Single-Center One-Year Experience [Response to Letter] DOI Creative Commons

Lisa Taruffi,

Lorenzo Muccioli, Francesca Bisulli

et al.

Neuropsychiatric Disease and Treatment, Journal Year: 2023, Volume and Issue: Volume 19, P. 1985 - 1986

Published: Sept. 1, 2023

We read with great interest the letter by Li et al regarding role of acupuncture and moxibustion in treatment long-term effects COVID-19.While we have established therapeutic patterns for acute COVID-19, there are no standard strategies manifestations, which extremely variegated include numerous neuropsychiatric symptoms. 1,2The high prevalence anxiety or depressive symptoms among those who experienced even mild infections from SARS-CoV-2 suggests that should not be limited to pharmacological but involve psychological support. 3 It is worth noting traditional Chinese medicine still widely recognized Europe, its has been marginal managing COVID-19 pandemic most European American countries.Although included options conditions such as tension-type headache, migraine, fibromyalgia, 4 long-COVID yet defined.Regarding moxibustion, lack scientific evidence effectiveness obtained via clinical trials prevents diffusion Europe US.One recent scoping reviews 5 pointed out their possible guidelines, systematic reviews, trials, observational studies, protocols.However, recommendations on guidelines consensuses based experts' experience opinions lacked details operation process, determining difficulty developing common strategies.Nonetheless, interventions were often combined other methods (as Western medicine, etc.), so, reported, results may exaggerate moxibustion. 5Furthermore, further limitations instance, sample sizes randomized controlled frequently used subjective outcomes predict ago puncture ie self-reporting questionnaires. 6 A correct approach management arguably start development validation biomarkers contributing making an accurate diagnosis serving purpose objectively delineating responses treatment. 7While effective treatments lacking, certain myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) like pacing specific medications promising.Low-dose naltrexone antihistamines provide relief, while BC007 targets autoimmunity anticoagulants address abnormal clotting.Apheresis supplements (coenzyme Q10, d-ribose) seem offer potential benefits.Case reports studies highlight additional options: Paxlovid ameliorate symptoms, sulodexide reduces severity burden, probiotics show effectiveness, stellate ganglion block appears alleviate dysautonomia, Pycnogenol improves physiological measures quality life.

Language: Английский

Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report DOI Open Access
Pushpa Tandon, Natalie Abrams, Leela Rani Avula

et al.

The Journal of Immunology, Journal Year: 2024, Volume and Issue: 212(4), P. 505 - 512

Published: Feb. 5, 2024

As COVID-19 continues, an increasing number of patients develop long COVID symptoms varying in severity that last for weeks, months, or longer. Symptoms commonly include lingering loss smell and taste, hearing loss, extreme fatigue, "brain fog." Still, persistent cardiovascular respiratory problems, muscle weakness, neurologic issues have also been documented. A major problem is the lack clear guidelines diagnosing COVID. Although some studies suggest due to prolonged inflammation after SARS-CoV-2 infection, underlying mechanisms remain unclear. The broad range COVID-19's bodily effects responses initial viral infection are poorly understood. This workshop brought together multidisciplinary experts showcase discuss latest research on chronic might be associated with sequelae following infection.

Language: Английский

Citations

11

Stress and Inflammation Target Dorsolateral Prefrontal Cortex Function: Neural Mechanisms Underlying Weakened Cognitive Control DOI Creative Commons
Mary Kate P. Joyce, Stacy Uchendu,

Amy Arnsten

et al.

Biological Psychiatry, Journal Year: 2024, Volume and Issue: unknown

Published: June 1, 2024

Language: Английский

Citations

11

Cognitive Sequelae of COVID‐19: Mechanistic Insights and Therapeutic Approaches DOI Creative Commons
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang

et al.

CNS Neuroscience & Therapeutics, Journal Year: 2025, Volume and Issue: 31(3)

Published: March 1, 2025

ABSTRACT Background The COVID‐19 pandemic has left an indelible mark on the world, with mounting evidence suggesting that it not only posed acute challenges to global healthcare systems but also unveiled a complex array of long‐term consequences, particularly cognitive impairment (CI). As persistence post‐COVID‐19 neurological syndrome could evolve into next public health crisis, is imperative gain better understanding intricate pathophysiology CI in patients and viable treatment strategies. Methods This comprehensive review explores management across phases COVID‐19, from infection Long‐COVID, by synthesizing findings clinical, preclinical, mechanistic studies identify key contributors CI, as well current therapeutic approaches. Results Key mechanisms contributing include persistent neuroinflammation, cerebrovascular complications, direct neuronal injury, activation kynurenine pathway, psychological distress. Both pharmacological interventions, such anti‐inflammatory therapies agents targeting neuroinflammatory pathways, non‐pharmacological strategies, including rehabilitation, show promise addressing these challenges. Although much derived preclinical animal studies, provide foundational insights potential Conclusion By knowledge, this highlights importance COVID‐19‐related offers actionable for mitigation recovery community continues grapple pandemic's impact.

Language: Английский

Citations

0

Greater executive dysfunction in patients post-COVID-19 compared to those not infected DOI
Jacqueline Becker, Jenny J. Lin,

Akosua Twumasi

et al.

Brain Behavior and Immunity, Journal Year: 2023, Volume and Issue: 114, P. 111 - 117

Published: Aug. 14, 2023

Language: Английский

Citations

10

Longitudinal Exploration of Cortical Brain Activity in Cognitive Fog: An EEG Study in Patients with and without Anosmia DOI Creative Commons
Antonio Gangemi, Rossella Suriano, Rosa Angela Fabio

et al.

Journal of Integrative Neuroscience, Journal Year: 2024, Volume and Issue: 23(5)

Published: May 20, 2024

Background: Long-Covid, characterized by persistent symptoms following acute Covid-19 infection, represents a complex challenge for the scientific community. Among most common and debilitating manifestations, cognitive fog is neurological disorder mental confusion difficulties. In this study, we investigated long-term effects of previous infection on cortical brain activity in patients experiencing medium long term. Methods: A total 40 subjects (20 females 20 males) aged between 45 70 years (mean age (M) = 59.78, standard deviation (SD) 12.93) participated study. This sample included individuals with fog, both without anosmia, control group comprised healthy subjects. All electroencephalography (EEG) data were collected two sessions, 1 month 8 months after recovery from Covid-19, to measure neurophysiological parameters P300 beta band rhythms. Results: The results revealed significant differences rhythms affected these alterations persist even Covid-19. Interestingly, no observed participants anosmia associated fog. Conclusions: These findings provide contribution understanding have important implications future interventions aimed at managing treating symptoms. longitudinal assessment helps highlight impact virus health Long-Covid patients.

Language: Английский

Citations

3

CURRENT CONCEPTS IN LONG-COVID BRAIN FOG AND POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME DOI
Jinny Tavee

Annals of Allergy Asthma & Immunology, Journal Year: 2024, Volume and Issue: 133(5), P. 522 - 530

Published: Aug. 23, 2024

Language: Английский

Citations

3

Combined Use of Guanfacine and N-Acetylcysteine for the Treatment of Cognitive Deficits After Traumatic Brain Injury DOI Creative Commons
Siddharth Khasnavis,

Timothy Belliveau,

Amy F.T. Arnsten

et al.

Neurotrauma Reports, Journal Year: 2024, Volume and Issue: 5(1), P. 226 - 231

Published: March 1, 2024

Traumatic Brain Injury (TBI) is a significant contributor to disability across the world. TBIs vary in severity, and most cases are designated mild TBI (mTBI), involving only brief loss of consciousness no intracranial findings on imaging. Despite this categorization, many persons continue report persistent cognitive changes months years after injury, with particular impairment executive functions pre-frontal cortex. For these persons, there currently approved medications, treatment limited symptom management or behavioral therapy. The current case studies explored use alpha-2A adrenoreceptor agonist, guanfacine, combined antioxidant,

Language: Английский

Citations

2

Cardiopulmonary rehabilitation’s influence on cognitive functions, psychological state, and sleep quality in long COVID-19 patients: A randomized controlled trial DOI
Flavie Gaudreau-Majeau,

Christine Gagnon,

Sarah Clavet Djedaa

et al.

Neuropsychological Rehabilitation, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 17

Published: April 12, 2024

Background: Cognitive impairment, brain fog, depressive symptoms, and sleep disturbance are prevalent symptoms among individuals with long COVID, for which there currently is no treatment. Aim: To assess the effectiveness of an eight-week cardiopulmonary rehabilitation programme on cognition, psychological well-being, quality in COVID-19. Methods: Forty participants diagnosed COVID-19 (26 female, 14 male participants; mean age 53 ± 11 years) were randomly assigned to a group or control group. The maintained their regular daily habits, while was prescribed individualized clinical consisting three sessions per week. Each session involved light moderate aerobic exercise, resistance training, respiratory exercises. Neuropsychological tests evaluating executive function, memory, processing speed administered at baseline study completion. Participants also completed questionnaires state both time points. Results: No difference between groups observed neuropsychological test performance, however significant differences perceived stress depression found post-intervention. Conclusion: Cardiopulmonary shown be effective suffering from COVID terms decreasing levels but not performance.

Language: Английский

Citations

1

The association between memory, COVID-19 testing, and COVID-19 incidence in middle-aged and older adults: a prospective analysis of the CLSA DOI
Mark Oremus, Suzanne L. Tyas, Leilei Zeng

et al.

Aging Neuropsychology and Cognition, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 18

Published: April 16, 2024

We investigated the association between pre-COVID-19 memory function and (a) receipt of a COVID-19 test (b) incidence using Questionnaire Study (CQS) Canadian Longitudinal on Aging (CLSA). The CQS included 28,565 middle-aged older adults. regressed participants' immediate delayed recall scores re-ran regression models with as outcome. All were adjusted for sociodemographic, lifestyle, health covariates. In analytical sample (n = 21,930), higher (better memory) was significantly associated lower incidence. However, this not significant memory. Immediate test. Health policymakers practitioners may viewmemory status potential risk COVID-19. Memory be barrier to testing.

Language: Английский

Citations

1

How Mild Is the Mild Long COVID? A Comprehensive Neuropsychological Assessment of Patients with Cognitive Complaints DOI
Lucas Emmanuel Lopes e Santos,

Diego de Lacerda Ferreira,

Geisa de Angelis

et al.

Archives of Clinical Neuropsychology, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 23, 2024

The global impact of the Coronavirus Disease (COVID-19) pandemic has extended beyond physical health, leading to widespread mental health issues. Beyond respiratory symptoms, there is a growing concern about long-term cognitive effects, particularly in individuals who experienced mild cases infection. We aimed investigate neuropsychological aspects COVID-19 non-hospitalized adults compared with control group. This cross-sectional study included 42 participants, 22 history COVID, and 20 healthy controls. participants were recruited from community underwent comprehensive assessment. Participants COVID group reported symptoms persisting for an average 203.86 days presented higher frequency psychological treatment (81.8%) (25.0%). History anxiety disorders was more prevalent (63.6%) than (20.0%). Significant reductions verbal working memory observed Levels found have significant on difficulties visual recognition memory. reveals important alterations following COVID-19, emphasizing executive functions deficits. Our findings underscore persistence these deficits even cases, suggesting potential inflammatory mechanisms central nervous system. highlights need assessments targeted interventions address diverse impacts recovering COVID-19.

Language: Английский

Citations

0